| Mittal Patel, APN | |
|
5 Franklin Ave, Belleville, NJ 07109 | |
| (973) 240-9089 | |
| Not Available |
| Full Name | Mittal Patel |
|---|---|
| Gender | Female |
| Speciality | Allergy & Immunology |
| Location | 5 Franklin Ave, Belleville, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093229619 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 26NJ00776600 (New Jersey) | Secondary |
| 207K00000X | Allergy & Immunology | 26NJ00776600 (New Jersey) | Primary |
| Entity Name | Optum Medical Care Of New Jersey Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578665048 PECOS PAC ID: 3072650290 Enrollment ID: O20091021000129 |
News Archive
Politico is reporting on its Political Intelligence Blog that Vice President Joe Biden, subbing for President Obama who is at the G-8 economic summit in Italy, formally announced the latest deal with the industry. "The nation's hospitals have tentatively agreed to forego about $155 billion in government payments for Medicaid and Medicare over the next decade - about 20 percent of the $1 trillion projected to be needed to extend health coverage to about 47 million uninsured Americans."
Highlighting a recent report by the Journal of the Royal Society of Medicine about the use of the drug misoprostol to prevent postpartum hemorrhage and the WHO's inclusion of the drug on its Essential Medicine List, Guardian health editor Sarah Boseley writes in this post in her "Global Health Blog," "Seldom has there been a drug that has excited as much controversy as misoprostol."
A chance meeting between a spider expert and a chemist has led to the development of antibiotic synthetic spider silk.
Spherix Incorporated - an intellectual property development company committed to the fostering and monetization of intellectual property, today provided an update on the September 2014 request for inter parties review by VTech Communications, Inc. and Uniden America Corporation.
Scientists from the Florida campus of The Scripps Research Institute have identified a molecular interaction between a structural hepatitis C virus protein (HCV) and a protein critical to viral replication. This new finding strongly suggests a novel method of inhibiting the production of the virus and a potential new therapeutic target for hepatitis C drug development.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mittal Patel, APN 33 Hudson St, Jersey City, NJ 07302-6575 Ph: (012) 434-7182 | Mittal Patel, APN 5 Franklin Ave, Belleville, NJ 07109 Ph: (973) 240-9089 |
News Archive
Politico is reporting on its Political Intelligence Blog that Vice President Joe Biden, subbing for President Obama who is at the G-8 economic summit in Italy, formally announced the latest deal with the industry. "The nation's hospitals have tentatively agreed to forego about $155 billion in government payments for Medicaid and Medicare over the next decade - about 20 percent of the $1 trillion projected to be needed to extend health coverage to about 47 million uninsured Americans."
Highlighting a recent report by the Journal of the Royal Society of Medicine about the use of the drug misoprostol to prevent postpartum hemorrhage and the WHO's inclusion of the drug on its Essential Medicine List, Guardian health editor Sarah Boseley writes in this post in her "Global Health Blog," "Seldom has there been a drug that has excited as much controversy as misoprostol."
A chance meeting between a spider expert and a chemist has led to the development of antibiotic synthetic spider silk.
Spherix Incorporated - an intellectual property development company committed to the fostering and monetization of intellectual property, today provided an update on the September 2014 request for inter parties review by VTech Communications, Inc. and Uniden America Corporation.
Scientists from the Florida campus of The Scripps Research Institute have identified a molecular interaction between a structural hepatitis C virus protein (HCV) and a protein critical to viral replication. This new finding strongly suggests a novel method of inhibiting the production of the virus and a potential new therapeutic target for hepatitis C drug development.
› Verified 8 days ago